Accolades

Recognized as the Hatch-Waxman Litigation Firm of the Year by LMG Life Sciences

September 13, 2018

LMG Life Sciences announced that the firm’s Intellectual Property practice was honored at the LMG Life Sciences Awards as the Hatch-Waxman Litigation Firm of the Year (Branded). The publication cited the firm for wins on behalf of Sunovion Pharmaceuticals, which locked in compound patent protection for Latuda®, the company’s billion-dollar-plus-per-year schizophrenia and bipolar drug, after a judgment of infringement that was affirmed by the Federal Circuit; and for Orexigen Therapeutics after a trial victory where the judge found all three patents-in-suit to be valid and infringed. The firm was also noted for obtaining an unprecedented six walk-away consent judgments in a major pharmaceutical litigation.

The firm and its partners were also shortlisted for:* Inter-Partes Review Firm of the Year* Post Grant Proceedings Attorney of the Year: Naveen Modi* General Patent Litigator of the Year – New York: Bruce Wexler